JP2005530730A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530730A5
JP2005530730A5 JP2003584041A JP2003584041A JP2005530730A5 JP 2005530730 A5 JP2005530730 A5 JP 2005530730A5 JP 2003584041 A JP2003584041 A JP 2003584041A JP 2003584041 A JP2003584041 A JP 2003584041A JP 2005530730 A5 JP2005530730 A5 JP 2005530730A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
independently
amino
fully halogenated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003584041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530730A (ja
JP4578106B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/011094 external-priority patent/WO2003087085A1/en
Publication of JP2005530730A publication Critical patent/JP2005530730A/ja
Publication of JP2005530730A5 publication Critical patent/JP2005530730A5/ja
Application granted granted Critical
Publication of JP4578106B2 publication Critical patent/JP4578106B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003584041A 2002-04-11 2003-04-10 サイトカインインヒビターとしてのヘテロ環式アミド誘導体 Expired - Lifetime JP4578106B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37167102P 2002-04-11 2002-04-11
PCT/US2003/011094 WO2003087085A1 (en) 2002-04-11 2003-04-10 Heterocyclic amide derivatives as cytokine inhibitors

Publications (3)

Publication Number Publication Date
JP2005530730A JP2005530730A (ja) 2005-10-13
JP2005530730A5 true JP2005530730A5 (enExample) 2006-06-08
JP4578106B2 JP4578106B2 (ja) 2010-11-10

Family

ID=29250721

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003584041A Expired - Lifetime JP4578106B2 (ja) 2002-04-11 2003-04-10 サイトカインインヒビターとしてのヘテロ環式アミド誘導体

Country Status (9)

Country Link
US (1) US7550461B2 (enExample)
EP (1) EP1497278B1 (enExample)
JP (1) JP4578106B2 (enExample)
AT (1) ATE469142T1 (enExample)
AU (1) AU2003224923A1 (enExample)
CA (1) CA2478232C (enExample)
DE (1) DE60332717D1 (enExample)
ES (1) ES2343787T3 (enExample)
WO (1) WO2003087085A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1497278B1 (en) * 2002-04-11 2010-05-26 Boehringer Ingelheim Pharmaceuticals Inc. Heterocyclic amide derivatives as cytokine inhibitors
US7078419B2 (en) * 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
EP1867646A1 (en) * 2004-05-03 2007-12-19 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
US7285545B2 (en) 2004-05-03 2007-10-23 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
WO2006026235A1 (en) * 2004-08-25 2006-03-09 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
WO2006062982A2 (en) * 2004-12-07 2006-06-15 Locus Pharmaceuticals, Inc. Urea inhibitors of map kinases
US7612200B2 (en) * 2004-12-07 2009-11-03 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
EP1838690A2 (en) * 2004-12-21 2007-10-03 Devgen N.V. Compounds with kv4 ion channel activity
US8957070B2 (en) 2005-04-20 2015-02-17 Takeda Pharmaceutical Company Limited Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
CA2635888A1 (en) * 2006-01-04 2007-07-19 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
JP5216912B2 (ja) 2008-04-29 2013-06-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr1受容体拮抗薬としてのインダゾール化合物
JP5411927B2 (ja) * 2008-05-06 2014-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr1アンタゴニストとしてのピラゾール化合物
EP2161266A1 (en) * 2008-08-22 2010-03-10 EVOTEC Neurosciences GmbH Benzofuran derivatives as orexin receptor antagonists
PE20110854A1 (es) 2008-09-26 2011-12-23 Boehringer Ingelheim Int DERIVADOS DE 1-FENIL-1H-PIRAZOLO[3,4-c]PIRIDINA-4-CARBONILAMINA COMO ANTAGONISTAS DE LOS RECEPTORES CCR1
AP2012006204A0 (en) 2009-10-21 2012-04-30 Boehringer Ingelheim Int Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists.
JP5542214B2 (ja) 2009-10-27 2014-07-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr1受容体アンタゴニストとしての複素環化合物
US8871786B2 (en) 2010-04-30 2014-10-28 Boehringer Ingelheim International Gmbh Azaindazole amide compounds as CCR1 receptor antagonists
US8546442B2 (en) 2010-12-23 2013-10-01 Boehringer Ingelheim International Gmbh Pyrazolopiperidine compounds as CCR1 receptor antagonists
CN121695288A (zh) 2020-02-19 2026-03-20 Epizyme股份有限公司 Setd2抑制剂和相关方法和用途,包括组合疗法
CN117510460B (zh) * 2023-10-30 2026-02-06 贵州大学 一种含磺酰胺单元的苯并[b]噻吩衍生物、其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317076A1 (de) * 1993-05-21 1994-11-24 Bayer Ag Benzthiophencarbonsäureamid-S-oxide
DE19642529A1 (de) * 1996-10-15 1998-04-16 Bayer Ag Aminophenolderivate
US5994398A (en) * 1996-12-11 1999-11-30 Elan Pharmaceuticals, Inc. Arylsulfonamides as phospholipase A2 inhibitors
US6579872B1 (en) * 1998-05-15 2003-06-17 Astrazeneca Ab Bezamide derivatives for the treatment of diseases mediated by cytokines
ATE254105T1 (de) 1998-09-25 2003-11-15 Astrazeneca Ab Benzamid-derivate und ihre verwendung als cytokine inhibitoren
TR200102817T2 (tr) 1999-03-12 2002-05-21 Boehringer Ingelheim Pharmaceuticals, Inc. Antiinflamatuar ajanlar olarak faydalı bileşikler
TWI288745B (en) * 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2002012189A1 (en) * 2000-08-09 2002-02-14 Mitsubishi Pharma Corporation Fused bicyclic amide compounds and medicinal use thereof
MXPA03009000A (es) 2001-04-13 2004-02-12 Boehringer Ingelheim Pharma Compuestos benzo-fusionados 1,4-disustituidos.
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
EP1497278B1 (en) * 2002-04-11 2010-05-26 Boehringer Ingelheim Pharmaceuticals Inc. Heterocyclic amide derivatives as cytokine inhibitors

Similar Documents

Publication Publication Date Title
JP2000515136A (ja) プロテインチロシンキナーゼ阻害剤としての二環式ヘテロ芳香族化合物
JP5735986B2 (ja) 新規抗マラリア剤
JP2005519932A5 (enExample)
JP2007536231A5 (enExample)
CA2478232A1 (en) Heterocyclic amide derivatives as cytokine inhibitors
EA002113B1 (ru) Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
SK133297A3 (en) Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use
BG64211B1 (bg) Заместени индазолови производни и тяхното използване като инхибитори на фосфодиестераза (pde) тип iv и на произвеждането на туморен некрозен фактор (tnf)
US20040147546A1 (en) Heterocyclic compounds
JP2002538157A (ja) ピラゾロピリジン
JP2005511532A5 (enExample)
JP2007537255A5 (enExample)
JP2005509003A5 (enExample)
JP2010116403A (ja) 4−ピリジルアルキルチオ基を置換基として有する新規化合物
JPS62452A (ja) 1,8−架橋−4−キノロン−3−カルボン酸類の製造法、それらの中間体類、および薬物としてのそれらの使用
JP2006514940A5 (enExample)
HRP20030141A2 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
CA2507184A1 (en) 1, 2, 3- triazole amide derivatives as cytokine inhibitors
RU2004112781A (ru) Производные пиперидина и их применение в качестве модуляторов активности рецепторов хемокинов (в частности ccr5)
CA3022102A1 (en) Benzoylglycine derivatives and methods of making and using same
WO2006064957A1 (ja) アミド化合物及びトロンボポエチンレセプター活性化剤
CA2483345A1 (en) Imidazolinylmethyl aralkylsulfonamides
JP2005508954A5 (enExample)
CN1004274B (zh) 4-烷氧基-吡啶并[2,3-d]嘧啶-衍生物的制造方法
TW202547506A (zh) Slc6a19抑制劑化合物、藥物組合物及其製備方法和用途